A recent study conducted by Dr. med. Michael Winkelmann and his colleagues at the LMU Klinikum München explored the association between TGR dynamics from pre-treatment to post-treatment imaging and the patients' outcomes.
The research provides valuable insights into the potential of TGR as a novel prognostic imaging biomarker in the context of CAR-T therapy for patients with relapsed or refractory non-Hodgkin's lymphoma.
Study with mint Lesion™ Uncovers the Impact of Tumor Growth Rate in Predicting the Efficacy of CAR-T-cell Therapy in Lymphoma Patients
Related Resources
Related Resources
Multicentric Study: Comparison of Diagnostic Guidelines for Hepatocellular Carcinoma
Recent advancements in MRI techniques and tumor biology have led to updated hepatocellular carcinoma (HCC) diagnostic guidelines from various liver…
RACOON: A Guide to Bridging the Gap Between Simulated and Real-World Federated Learning Research
Deep learning (DL) has become an important part of radiological image analysis. To train these deep-learning models, access to large and diverse…
RACOON: Study emphasizes the clinical relevance of pericardial effusion as an imaging biomarker in COVID-19 patients
A multicenter study [1] based on the German research infrastructure project RACOON (Radiological Cooperative Network of the COVID-19 pandemic; a Netzw…